secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001493152-26-021658
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants CURX additional 180 days until Nov 2, 2026 to meet $1 bid price
-----------------------------------------------------------------------------

- Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00; initial 180-day period ended May 4, 2026.
- Nasdaq granted second 180-day compliance period through Nov 2, 2026, based on meeting other listing requirements.
- Company may implement a reverse stock split to cure the deficiency.
- If bid price stays at $1.00 for 10 consecutive days during extension, compliance will be confirmed.
- Failure to regain compliance by Nov 2, 2026 could result in delisting, with appeal rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/0001493152-26-021658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer